BIOTECH

BIOTECH

AUM Biosciences announces closing of $27 million in a “Series A” Round of funding to advance its clinical stage pipeline of precision and targeted cancer therapies

SINGAPORE and NEW YORK, October 12, 2021 – AUM Biosciences (AUM) today announced the successful completion of...

Read more

BIOTECH

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

NEW YORK and SINGAPORE – June 11, 2020 – Travecta Therapeutics, a biopharmaceutical company pioneering...

Read more

BIOTECH

Travecta Therapeutics Secures $15 Million in Financing

NEW YORK and SINGAPORE – May 12, 2020 – Travecta Therapeutics, a biopharmaceutical company developing...

Read more